Description
Composition (Each Tablet Contains):
-
Mefenamic Acid – 500 mg
-
Paracetamol – 325 mg
Form: Oral Tablet
Pack Size: 10×10 Alu-Alu
Product Description:
PARADEL®-MF is a clinically trusted combination of Mefenamic Acid and Paracetamol, formulated for effective relief from moderate to severe pain, especially in dysmenorrhea (menstrual cramps), muscle aches, joint pain, toothache, and fever. Mefenamic Acid acts as a potent NSAID to reduce inflammation, while Paracetamol enhances pain control and manages fever.
It is widely used in gynecological, orthopedic, and dental practice for its rapid onset of action, superior tolerability, and effective pain suppression.
Key Benefits:
-
Relieves muscle and joint pain, including sprains and strains
-
Effective in menstrual cramps and pelvic pain
-
Provides fever reduction with improved safety profile
-
Suitable for dental pain, post-surgical pain, and headaches
-
Dual mechanism for faster, longer-lasting relief
How It Works:
-
Mefenamic Acid reduces inflammation by blocking COX enzymes and prostaglandin production at the pain site
-
Paracetamol acts centrally to relieve pain and control body temperature
Together, they provide faster pain relief and longer duration of action with reduced gastric irritation compared to NSAIDs alone.
How to Use:
-
Take 1 tablet two to three times daily, after meals, or as directed by your doctor
-
Swallow whole with water—do not crush or chew
-
Do not exceed the recommended dose
Safety Advice:
-
Take after food to minimize gastric discomfort
-
Avoid alcohol or other NSAIDs during treatment
-
Do not use for more than 5 days without medical advice
-
Use with caution in people with liver or kidney disease
Precautions:
-
Not recommended during pregnancy (especially 3rd trimester) and breastfeeding
-
Avoid in patients with a history of gastric ulcers, bleeding disorders, or aspirin sensitivity
-
Consult your doctor if taking anticoagulants or diuretics
-
Store in a cool, dry place away from direct light and moisture
Reviews
There are no reviews yet.